Stock Screener
Stock Research
Delisted Stocks
Market Indexes
Precious Metals
Energy
Commodities
Interest Rates
Economy
Global Metrics

Merck Gross Profit 2010-2024 | MKGAF

Merck annual/quarterly gross profit history and growth rate from 2010 to 2024. Gross profit can be defined as the profit a company makes after deducting the variable costs directly associated with making and selling its products or providing its services.
  • Merck gross profit for the quarter ending June 30, 2024 was $3.482B, a 0.95% increase year-over-year.
  • Merck gross profit for the twelve months ending June 30, 2024 was $13.149B, a 7.19% decline year-over-year.
  • Merck annual gross profit for 2023 was $13.413B, a 7.11% decline from 2022.
  • Merck annual gross profit for 2022 was $14.44B, a 1.06% decline from 2021.
  • Merck annual gross profit for 2021 was $14.595B, a 19.42% increase from 2020.
  
Merck Annual Gross Profit
(Millions of US $)
2023 $13,413
2022 $14,440
2021 $14,595
2020 $12,221
2019 $11,364
2018 $11,165
2017 $11,311
2016 $10,870
2015 $9,730
2014 $10,600
2013 $10,763
2012 $10,308
2011 $9,915
2010 $12,338
2009 $10,807
Merck Quarterly Gross Profit
(Millions of US $)
2024-06-30 $3,482
2024-03-31 $3,267
2023-12-31 $3,123
2023-09-30 $3,277
2023-06-30 $3,449
2023-03-31 $3,564
2022-12-31 $3,470
2022-09-30 $3,685
2022-06-30 $3,681
2022-03-31 $3,603
2021-12-31 $3,731
2021-09-30 $3,672
2021-06-30 $3,683
2021-03-31 $3,508
2020-12-31 $3,340
2020-09-30 $3,122
2020-06-30 $2,763
2020-03-31 $2,996
2019-12-31 $2,987
2019-09-30 $2,865
2019-06-30 $2,829
2019-03-31 $2,683
2018-12-31 $2,601
2018-09-30 $2,796
2018-06-30 $2,854
2018-03-31 $2,914
2017-12-31 $2,908
2017-09-30 $2,854
2017-06-30 $2,816
2017-03-31 $2,734
2016-12-31 $2,696
2016-09-30 $2,760
2016-06-30 $2,813
2016-03-31 $2,601
2015-12-31 $2,537
2015-09-30 $2,444
2015-06-30 $2,437
2015-03-31 $2,366
2014-12-31 $2,114
2014-09-30 $2,638
2014-06-30 $2,690
2014-03-31 $2,644
2013-12-31 $2,672
2013-09-30 $2,687
2013-06-30 $2,767
2013-03-31 $2,625
2012-12-31 $3,646
2012-09-30 $2,570
2012-06-30 $2,482
2012-03-31 $3,274
2011-12-31 $3,311
2011-09-30 $3,585
2011-06-30 $2,583
2011-03-31 $3,505
2010-12-31 $3,707
2010-09-30 $2,345
2010-06-30 $2,695
2010-03-31 $2,791
2009-12-31 $2,983
2009-09-30 $2,778
2009-06-30 $2,590
2009-03-31 $2,456
Sector Industry Market Cap Revenue
Medical Medical - Drug Manufacturing $23.031B $22.719B
Merck is a global pharmaceutical and chemical company. Its success is characterized by innovations from entrepreneurial employees. Merck's operating activities come under the umbrella of Merck KGaA, in which the Merck family holds an approximately 70% interest and free shareholders own the remaining approximately 30%. In 1917 the U.S. subsidiary Merck & Co. was expropriated and has been an independent company ever since.
Stock Name Country Market Cap PE Ratio
Zoetis (ZTS) United States $88.286B 35.17
Takeda Pharmaceutical (TAK) Japan $46.614B 9.33
Astellas Pharma (ALPMY) Japan $21.569B 25.91
Sandoz Group AG (SDZNY) Switzerland $18.132B 0.00
Summit Therapeutics (SMMT) United States $16.527B 0.00
United Therapeutics (UTHR) United States $15.915B 16.44
Shionogi (SGIOY) Japan $13.333B 12.77
Neurocrine Biosciences (NBIX) United States $11.706B 35.02
Catalent (CTLT) United States $10.940B 0.00
Orion OYJ (ORINY) Finland $7.664B 31.21
Revolution Medicines (RVMD) United States $7.326B 0.00
Jazz Pharmaceuticals (JAZZ) Ireland $6.805B 7.22
Ionis Pharmaceuticals (IONS) United States $6.009B 0.00
Hikma Pharmaceuticals Plc (HKMPF) United Kingdom $5.660B 0.00
Madrigal Pharmaceuticals (MDGL) United States $4.644B 0.00
Corcept Therapeutics (CORT) United States $4.522B 38.30
Crinetics Pharmaceuticals (CRNX) United States $4.048B 0.00
Dyne Therapeutics (DYN) United States $3.476B 0.00
PTC Therapeutics (PTCT) United States $2.897B 0.00
AMNEAL PHARMACEUTICALS, INC (AMRX) United States $2.585B 14.91
Arrowhead Pharmaceuticals (ARWR) United States $2.439B 0.00
Catalyst Pharmaceuticals (CPRX) United States $2.368B 18.82
Recursion Pharmaceuticals (RXRX) United States $2.016B 0.00
Soleno Therapeutics (SLNO) United States $1.896B 0.00
Centessa Pharmaceuticals (CNTA) United Kingdom $1.776B 0.00
Xencor (XNCR) United States $1.595B 0.00
Harrow (HROW) United States $1.569B 0.00
BioCryst Pharmaceuticals (BCRX) United States $1.568B 0.00
Cassava Sciences (SAVA) United States $1.529B 0.00
Ardelyx (ARDX) United States $1.497B 0.00
NewAmsterdam Pharma (NAMS) Netherlands $1.425B 0.00
ARS Pharmaceuticals (SPRY) United States $1.407B 0.00
Ocular Therapeutix (OCUL) United States $1.369B 0.00
Indivior (INDV) United States $1.368B 6.28
Collegium Pharmaceutical (COLL) United States $1.239B 7.11
Evotec AG (EVO) Germany $1.237B 0.00
Avadel Pharmaceuticals (AVDL) Ireland $1.213B 0.00
Enliven Therapeutics (ELVN) United States $1.139B 0.00
Aurinia Pharmaceuticals Inc (AUPH) Canada $1.024B 0.00
Relay Therapeutics (RLAY) United States $0.991B 0.00
Bioventus (BVS) United States $0.895B 29.08
Cronos Group (CRON) Canada $0.837B 0.00
USANA Health Sciences (USNA) United States $0.721B 13.23
Savara (SVRA) United States $0.698B 0.00
Pacira BioSciences (PCRX) United States $0.661B 6.26
Ironwood Pharmaceuticals (IRWD) United States $0.649B 40.60
Exscientia (EXAI) United Kingdom $0.641B 0.00
Tourmaline Bio (TRML) United States $0.637B 0.00
ProKidney (PROK) United States $0.591B 0.00
4D Molecular Therapeutics (FDMT) United States $0.570B 0.00
Foghorn Therapeutics (FHTX) United States $0.536B 0.00
Silence Therapeutics (SLN) United Kingdom $0.522B 0.00
OmniAb (OABI) United States $0.500B 0.00
Siga Technologies (SIGA) United States $0.495B 5.93
Altimmune (ALT) United States $0.484B 0.00
Aquestive Therapeutics (AQST) United States $0.455B 0.00
Sage Therapeutics (SAGE) United States $0.438B 0.00
KalVista Pharmaceuticals (KALV) United States $0.432B 0.00
Xeris Biopharma Holdings (XERS) United States $0.422B 0.00
Verve Therapeutics (VERV) United States $0.420B 0.00
Elite Pharmaceuticals (ELTP) United States $0.416B 38.90
Larimar Therapeutics (LRMR) United States $0.404B 0.00
Theravance Biopharma (TBPH) Cayman Islands $0.394B 0.00
Lyell Immunopharma (LYEL) United States $0.389B 0.00
Zevra Therapeutics (ZVRA) United States $0.385B 0.00
Organogenesis (ORGO) United States $0.374B 0.00
Eliem Therapeutics (ELYM) United States $0.335B 0.00
Korro Bio (KRRO) United States $0.323B 0.00
Esperion Therapeutics (ESPR) United States $0.322B 0.00
Aldeyra Therapeutics (ALDX) United States $0.319B 0.00
Heron Therapeutics (HRTX) United States $0.311B 0.00
Lexeo Therapeutics (LXEO) United States $0.295B 0.00
Rigel Pharmaceuticals (RIGL) United States $0.282B 0.00
Akebia Therapeutics (AKBA) United States $0.280B 0.00
ESSA Pharma (EPIX) Canada $0.276B 0.00
Avita Medical (RCEL) United States $0.275B 0.00
Corbus Pharmaceuticals Holdings (CRBP) United States $0.259B 0.00
Nature's Sunshine Products (NATR) United States $0.250B 17.11
Black Diamond Therapeutics (BDTX) United States $0.249B 0.00
Nanobiotix S.A (NBTX) France $0.233B 0.00
Acrivon Therapeutics (ACRV) United States $0.225B 0.00
Enanta Pharmaceuticals (ENTA) United States $0.222B 0.00
Pyxis Oncology (PYXS) United States $0.221B 0.00
Amylyx Pharmaceuticals (AMLX) United States $0.218B 0.00
Nektar Therapeutics (NKTR) United States $0.204B 0.00
CytoDyn (CYDY) United States $0.193B 0.00
Profound Medical (PROF) Canada $0.192B 0.00
Telomir Pharmaceuticals (TELO) United States $0.191B 0.00
MediWound (MDWD) Israel $0.180B 0.00
Innate Pharma SA (IPHYF) France $0.180B 0.00
Galectin Therapeutics (GALT) United States $0.165B 0.00
Achieve Life Sciences (ACHV) Canada $0.152B 0.00
Cardiol Therapeutics (CRDL) Canada $0.148B 0.00
VAXART, INC (VXRT) United States $0.143B 0.00
Context Therapeutics (CNTX) United States $0.139B 0.00
Century Therapeutics (IPSC) United States $0.130B 0.00
Incannex Healthcare (IXHL) Australia $0.130B 0.00
Prelude Therapeutics (PRLD) United States $0.122B 0.00
Fractyl Health (GUTS) United States $0.121B 0.00
Assertio Holdings (ASRT) United States $0.116B 20.33
Journey Medical (DERM) United States $0.113B 0.00
Regulus Therapeutics (RGLS) United States $0.103B 0.00
OptiNose (OPTN) United States $0.103B 0.00
Relmada Therapeutics (RLMD) United States $0.099B 0.00
Marinus Pharmaceuticals (MRNS) United States $0.095B 0.00
Citius Pharmaceuticals (CTXR) United States $0.093B 0.00
AlloVir (ALVR) United States $0.090B 0.00
CASI Pharmaceuticals (CASI) China $0.089B 0.00
Karyopharm Therapeutics (KPTI) United States $0.088B 0.00
Aclaris Therapeutics (ACRS) United States $0.084B 0.00
Arch Biopartners (ACHFF) Canada $0.083B 0.00
PMV Pharmaceuticals (PMVP) United States $0.077B 0.00
Metagenomi (MGX) United States $0.076B 0.00
Swiftmerge Acquisition (IVCP) United States $0.076B 370.33
Verrica Pharmaceuticals (VRCA) United States $0.072B 0.00
Nutriband (NTRB) United States $0.070B 0.00
Champions Oncology (CSBR) United States $0.065B 0.00
Vivani Medical (VANI) United States $0.062B 0.00
SCYNEXIS (SCYX) United States $0.057B 0.00
Reneo Pharmaceuticals (RPHM) United States $0.054B 0.00
Mural Oncology (MURA) Ireland $0.052B 0.00
BioLineRx (BLRX) Israel $0.050B 0.00
Rafael Holdings (RFL) United States $0.048B 0.00
Gain Therapeutics (GANX) United States $0.047B 0.00
ProPhase Labs (PRPH) United States $0.043B 0.00
ElectroCore (ECOR) United States $0.043B 0.00
Carisma Therapeutics (CARM) United States $0.041B 0.00
Natural Alternatives (NAII) United States $0.040B 0.00
Inotiv (NOTV) United States $0.040B 0.00
Reviva Pharmaceuticals Holdings (RVPH) United States $0.040B 0.00
DURECT (DRRX) United States $0.040B 0.00
FibroGen (FGEN) United States $0.039B 0.00
Unicycive Therapeutics (UNCY) United States $0.039B 0.00
Protara Therapeutics (TARA) United States $0.038B 0.00
Enlivex Therapeutics (ENLV) Israel $0.034B 0.00
Surrozen (SRZN) United States $0.033B 0.00
Tempest Therapeutics (TPST) United States $0.033B 0.00
Oruka Therapeutics (ORKA) United States $0.029B 0.00
VYNE Therapeutics (VYNE) United States $0.028B 0.00
Lipocine (LPCN) United States $0.025B 0.00
MARKER THERAPEUTICS, INC (MRKR) United States $0.025B 0.00
Iterum Therapeutics (ITRM) Ireland $0.024B 0.00
MEI Pharma (MEIP) United States $0.019B 0.67
TherapeuticsMD (TXMD) United States $0.019B 0.00
Minerva Neurosciences (NERV) United States $0.019B 0.00
NRx Pharmaceuticals (NRXP) United States $0.018B 0.00
Cumberland Pharmaceuticals (CPIX) United States $0.017B 0.00
PolyPid (PYPD) Israel $0.017B 0.00
Lyra Therapeutics (LYRA) United States $0.016B 0.00
Cosmos Health (COSM) United States $0.015B 0.00
Mannatech (MTEX) United States $0.014B 0.00
Nuvilex (PMCB) United States $0.014B 0.00
XTL Biopharmaceuticals (XTLB) Israel $0.014B 0.00
Talphera (TLPH) United States $0.014B 0.00
Conduit Pharmaceuticals (CDT) United States $0.012B 0.00
Redhill Biopharma (RDHL) Israel $0.012B 0.00
Dominari Holdings (DOMH) United States $0.012B 0.00
GlycoMimetics (GLYC) United States $0.011B 0.00
Indaptus Therapeutics (INDP) United States $0.011B 0.00
Jaguar Animal Health (JAGX) United States $0.011B 0.00
TransCode Therapeutics (RNAZ) United States $0.011B 0.00
Vivos Therapeutics (VVOS) United States $0.010B 0.00
Kiora Pharmaceuticals (KPRX) United States $0.010B 0.00
Addex Therapeutics (ADXN) Switzerland $0.010B 0.00
Aptorum Group (APM) United Kingdom $0.010B 0.00
Avalo Therapeutics (AVTX) United States $0.010B 0.00
Plus Therapeutics (PSTV) United States $0.009B 0.00
Molecular Templates (MTEM) United States $0.009B 0.00
Viracta Therapeutics (VIRX) United States $0.009B 0.00
Inhibikase Therapeutics (IKT) United States $0.009B 0.00
BioVie (BIVI) United States $0.007B 0.00
Mangoceuticals (MGRX) United States $0.007B 0.00
Traws Pharma (TRAW) United States $0.006B 0.00
Xenetic Biosciences (XBIO) United States $0.006B 0.00
Alaunos Therapeutics (TCRT) United States $0.006B 0.00
Biomerica (BMRA) United States $0.006B 0.00
CERo Therapeutics Holdings (CERO) United States $0.005B 0.00
Galmed Pharmaceuticals (GLMD) Israel $0.005B 0.00
Oncternal Therapeutics (ONCT) United States $0.004B 0.00
Ainos (AIMD) United States $0.004B 0.00
Heatwurx (PCSA) United States $0.004B 0.00
TNF Pharmaceuticals (TNFA) United States $0.004B 0.00
Avenue Therapeutics (ATXI) United States $0.003B 0.09
Phio Pharmaceuticals (PHIO) United States $0.003B 0.00
Sonoma Pharmaceuticals (SNOA) United States $0.003B 0.00
XORTX Therapeutics (XRTX) Canada $0.003B 0.00
Shuttle Pharmaceuticals Holdings (SHPH) United States $0.003B 0.00
Tonix Pharmaceuticals Holding (TNXP) United States $0.003B 0.00
SciSparc (SPRC) Israel $0.002B 0.00
Bio-Path Holdings (BPTH) United States $0.002B 0.00
Petros Pharmaceuticals (PTPI) United States $0.002B 0.00
60 Degrees Pharmaceuticals (SXTP) United States $0.002B 0.00
Altamira Therapeutics (CYTO) Bermuda $0.002B 0.00
Qualigen Therapeutics (QLGN) United States $0.002B 0.00
Clearmind Medicine (CMND) Canada $0.002B 0.00
Quoin Pharmaceuticals (QNRX) United States $0.002B 0.00
Salarius Pharmaceuticals (SLRX) United States $0.002B 0.00
InMed Pharmaceuticals (INM) Canada $0.002B 0.00
SHINECO (SISI) China $0.002B 0.00
Universe Pharmaceuticals INC (UPC) China $0.001B 0.00
Aditxt (ADTX) United States $0.001B 0.00
PainReform (PRFX) Israel $0.000B 0.00
China SXT Pharmaceuticals (SXTC) China $0.000B 0.00
Qilian Holding Group (BGM) China $0.000B 0.00
Grifols, S.A (GRFS) Spain $0.000B 0.00
4D Pharma (LBPS) United Kingdom $0.000B 0.00
NLS Pharmaceutics (NLSP) Switzerland $0.000B 0.00
Procaps Group, S.A (PROC) Luxembourg $0.000B 4.15
Patheon (PTHN) Netherlands $0.000B 0.00
RVL Pharmaceuticals (RVLP) United States $0.000B 0.00
Stevanato Group S.p.A (STVN) Italy $0.000B 38.56